References
- American Psychiatric Association. “Benzodiazepine Dependence, Toxicity and Abuse — A Task Force Report of the American Psychiatric Association”. American Psychiatric Association, Washington, D.C. 19901. American Psychiatric Association. “Benzodiazepine Dependence, Toxicity and Abuse — A Task Force Report of the American Psychiatric Association”. American Psychiatric Association, WashingtonD.C. 1990
- Baker M. B., Manheimer D. I., Mellinger G. D., Uhlenhuth E. H. A cross-national comparison of anti-anxiety/sedative drug cse. Curr. Med. Res. Opin. 1984; 8: 5–20, Suppl. 42. Baker M. B., Manheimer D. I., Mellinger G. D., Uhlenhuth E. H. A cross-national comparison of anti-anxiety/sedative drug cse. Curr. Med. Res. Opin. 1984; 8: 5–20, Suppl. 4
- Lader M. The nature of clinical anxiety in modern society. “Stress and Anxiety”, C. D. Spielberger, I. G. Sarason. Halsted Press, New York 1975; 3–263. Lader M. The nature of clinical anxiety in modern society. “Stress and Anxiety”, C. D. Spielberger, I. G. Sarason. Halsted Press, New York 1975; 3–26
- Mellinger G. D., Baker M. B., Uhlenhuth E. H. Anti-anxiety agents: duration of use and characteristics of users in the U.S.A. Curr. Med. Res. Opin. 1984; 8: 21–35, Suppl. 44. Mellinger G. D., Baker M. B., Uhlenhuth E. H. Anti-anxiety agents: duration of use and characteristics of users in the U.S.A. Curr. Med. Res. Opin. 1984; 8: 21–35, Suppl. 4
- Mellinger G. D., Baker M. B., Uhlenhuth E. H. Prevalence and correlates of the long-term regular use of anxiolytics. J.A.M.A. 1984; 251: 375–3795. Mellinger G. D., Baker M. B., Uhlenhuth E. H. Prevalence and correlates of the long-term regular use of anxiolytics. J.A.M.A. 1984; 251: 375–379
- Rall T. W. “The Pharmacological Basis of Therapeutics”. McGraw-Hill, New York 1992; 346, Chap. 176. Rall T. W. “The Pharmacological Basis of Therapeutics”. McGraw-Hill, New York 1992; 346, Chap. 17